SpecialtyRx, Inc’s Post

Redefining CROs? Check out how ClinQure is taking a different approach. #ClinQure #ClinicalResearch #MedTechInnovation #CROs #QualityManagement

Thanks, Chris Fisher, for inviting The Rx Save Card to take the 3x3x3 challenge! The Rx Save Card is the perfect solution for self-funded employers that want to access lower prescription drug costs through Mark Cuban Cost Plus Drug Company, PBC, Cash Prices and Discount Cards without needing to change #PBMs. Employers are able to meet their #ERISA #Fiduciary obligations, while reducing their prescription drug spend. Employees get many drugs for free. A true win-win! https://lnkd.in/g-shm9E3

How can we help you? For example, is there one #MES issue you, your team, and your organization are tired of talking about? Stop by Exhibit W226 at ISPE Boston, and let’s talk about what you’re tired of talking about. #ISPEBoston #ISPE #Biotechnology #Pharma #LifeSciences

Here at Affygility Solutions, we often hear CDMO clients express their desire to handle Category 5 compounds. However, what they may not realize is the significant capital investment required to achieve this goal. Handling Category 5 compounds involves a variety of complex and costly measures, including facility modifications, investments in containment equipment, and personnel training. Moreover, the regulatory requirements for working with these compounds can be quite extensive. Therefore, it's important for organizations to carefully consider their goals and resources before pursuing the handling of Category 5 compounds. At Affygility Solutions, we work closely with clients to help them navigate these challenges and make informed decisions. cc/ Casey Cosner, PhD, CIH, CHMM #AffygilitySolutions #Category5Compounds #RegulatoryCompliance

How to finalize clinet project? 🤣

WATCH THE 𝐇𝐈𝐆𝐇𝐋𝐈𝐆𝐇𝐓𝐒 𝐎𝐅 𝐓𝐇𝐄 𝐒𝐂𝐑𝐌𝐏 𝐂𝐋𝐈𝐍𝐈𝐂𝐀𝐋 𝐑𝐄𝐒𝐄𝐀𝐑𝐂𝐇 𝐒𝐘𝐌𝐏𝐎𝐒𝐈𝐔𝐌 | 𝐃𝐀𝐘 𝟏 👉 𝗖𝗹𝗶𝗰𝗸 𝗵𝗲𝗿𝗲 𝘁𝗼 𝗪𝗮𝘁𝗰𝗵 𝘁𝗵𝗲 𝗙𝘂𝗹𝗹 𝗩𝗶𝗱𝗲𝗼: https://lnkd.in/gr4dWMqw #scrmp #ClinicalResearch #PharmacyWing #pharmd #medicalprofessionals #InaugurationHighlights #scrmpclinicalresearchsymposium

MEET THE PCSIG BOARD - Neil Spooner (Director Spooner Bioanalytical Solutions and Chair PCSIG) In the first of our "Meet the PCSIG Board" series, we hear from Neil Spooner. Please feel free to contact neil@pcsig.org if you have any questions. What excites you about PCSIG? - We have a unique community of passionate individuals and organisations that want to actively work together across organisational boundaries to help facilitate the more widespread understanding and adoption of patient centric sampling technologies and workflows, with the patient at the centre With our combined expertise and passion we will see a very different approach to the collection of human samples in the not too distant future. What do you bring to the PCSIG Board? - I bring endless amounts of energy and enthusiasm for patient centric approaches and a can do attitude for bringing individuals together to get stuff done, and not just talking about it. I also bring a broad network of individuals and organisations that share our passion for the more widespread understanding and adoption of patient centric sampling approaches. What do you want to hear from the PCSIG membership? - It is really important that we all share our experiences with PCS approaches, both our successes and challenges. This honest exchange of information and best practice can only accelerate the understanding of the technologies and associated workflows, easing their adoption and acceptance where they are appropriate, which in turn will lead to notable patient benefit. Knowing that there are others out there that are fighting the same battles is really important. Together we can make a positive difference for human well being.

The Drug Supply Chain Security Act was designed to protect patients by preventing counterfeit medications from entering the U.S. supply chain. Pharmacy experts explore the implications for providers and strategies to test pharmacy processes through the FDA stabilization period. #VerifiedRx #VizientPodcast

The Drug Supply Chain Security Act was designed to protect patients by preventing counterfeit medications from entering the U.S. supply chain. Pharmacy experts explore the implications for providers and strategies to test pharmacy processes through the FDA stabilization period. #VerifiedRx #VizientPodcast

The Drug Supply Chain Security Act was designed to protect patients by preventing counterfeit medications from entering the U.S. supply chain. Pharmacy experts explore the implications for providers and strategies to test pharmacy processes through the FDA stabilization period. #VerifiedRx #VizientPodcast